AbbVie Inc.
Time frame: 1 February 2023 - 31 January 2024Article ‘Count’ and ‘Share’ for AbbVie Inc. based on listed parameters only.
The articles listed below published by authors from AbbVie Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Annals of the Rheumatic Diseases |
1 | 0.36 |
Blood |
1 | 0.55 |
Brain |
1 | 0.83 |
Clinical Infectious Diseases |
1 | 0.01 |
Hepatology |
1 | 0.04 |
JAMA: The Journal of the American Medical Association |
1 | 0.02 |
Journal of Clinical Endocrinology & Metabolism |
1 | 0.27 |
Journal of the American Academy of Dermatology |
5 | 2.62 |
Nature |
1 | 0.48 |
Nature Communications |
3 | 0.11 |
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.03 |
The Lancet |
2 | 1.31 |
The New England Journal of Medicine |
3 | 1.03 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.